Kidney Medicine
Cost-Effectiveness of Dapagliflozin in the Treatment of Patients With Chronic Kidney Disease in Denmark
Computational studyInterventions
Papers by Morten Lindhardt
2 results
- ADA Scientific Sessions 2025 Abstract
Once-Weekly Semaglutide vs. Placebo for the Treatment of Type 2 Diabetes and Chronic Kidney Disease in Denmark—A Long-Term Cost-Effectiveness Analysis Based on Flow
Computational studyInterventions